Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP240483.RAaHneKuNsiaC-cUoJObxOUQBb8hyvw_W3WLy81sgvBMU130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240483.RAaHneKuNsiaC-cUoJObxOUQBb8hyvw_W3WLy81sgvBMU130_provenance.
• NP176788.RAj8IKWvgb27r-R2xTIulhSTtbTICoFewVP8s546IzZaA130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176788.RAj8IKWvgb27r-R2xTIulhSTtbTICoFewVP8s546IzZaA130_provenance.
• NP643115.RAee7_y0IH5IgD-3MnFeScHN1WqXcVo9rGkqn1BXTANFQ130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643115.RAee7_y0IH5IgD-3MnFeScHN1WqXcVo9rGkqn1BXTANFQ130_provenance.
• NP429158.RA6iHrWb4_OmWlbwraDzm307ds2mBJ96qFmLd-fNsKRSM130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429158.RA6iHrWb4_OmWlbwraDzm307ds2mBJ96qFmLd-fNsKRSM130_provenance.
• NP651280.RA5epVPXkWu1Sy65Uvhu5jRAA0p8W34LqeAYlG9yJJgdE130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651280.RA5epVPXkWu1Sy65Uvhu5jRAA0p8W34LqeAYlG9yJJgdE130_provenance.
• NP671063.RA2HqqtnMoDib9rapGzxHK2mvsl4P17PFQ0zizjyaj8dA130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671063.RA2HqqtnMoDib9rapGzxHK2mvsl4P17PFQ0zizjyaj8dA130_provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP836640.RAZzhpqYLep4kdsjvPsndFgYBsauzRIUmGvqcuX3DYV4Q130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836640.RAZzhpqYLep4kdsjvPsndFgYBsauzRIUmGvqcuX3DYV4Q130_provenance.
• NP836641.RARmiYN5jRw_FASxNTmubwV1hQrKBU7gwMEhG2wr9gMbM130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836641.RARmiYN5jRw_FASxNTmubwV1hQrKBU7gwMEhG2wr9gMbM130_provenance.
• NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_provenance.
• NP836642.RAgOiJ-gJNdJ85AcWGIpDIyNBCWwdY0dJqLfURtbTr4mo130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836642.RAgOiJ-gJNdJ85AcWGIpDIyNBCWwdY0dJqLfURtbTr4mo130_provenance.
• NP836644.RAoDeKNo1evIbdZRSLWd3gEd7zLB0moaUaSVC3VwKcbrM130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836644.RAoDeKNo1evIbdZRSLWd3gEd7zLB0moaUaSVC3VwKcbrM130_provenance.
• NP836643.RAOZUP0m-m70usRv6T4Vqf9RW7ytbhnlgAm9TRiVHZ6ME130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836643.RAOZUP0m-m70usRv6T4Vqf9RW7ytbhnlgAm9TRiVHZ6ME130_provenance.
• NP836639.RA7TFiUAtfXzjOnjAc1FzIRWLQ85hd63pdQjYSKbO306k130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836639.RA7TFiUAtfXzjOnjAc1FzIRWLQ85hd63pdQjYSKbO306k130_provenance.
• NP836645.RA0m91s1oKmHX0leks03WOeXeYLzBetX5RHz1-kciHL8I130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836645.RA0m91s1oKmHX0leks03WOeXeYLzBetX5RHz1-kciHL8I130_provenance.
• NP836648.RAy9dDiVbU4kZSf4eqOlzKjbZcrlJazWMXbMGL_J3Me0M130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836648.RAy9dDiVbU4kZSf4eqOlzKjbZcrlJazWMXbMGL_J3Me0M130_provenance.
• NP836649.RA4kmIhRsykopwg_UvX0eymy3K_KqWA2TGe63U5G6z4cs130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836649.RA4kmIhRsykopwg_UvX0eymy3K_KqWA2TGe63U5G6z4cs130_provenance.